[PainCube] Selected for the 2nd BiiG WAVE IR – Bio-Focused IR Program

StellarCube’s AI-powered pain management platform, PainCube, has been selected to participate in the 2nd BiiG WAVE IR Bio-Focused IR Program, hosted by the Incheon Center for Creative Economy & Innovation.

PainCube is an integrated pain management solution that uses AI to quantify and predict pain based on six or more types of multimodal biosignals, including ECG (electrocardiogram), SpO₂ (oxygen saturation), and HRV (heart rate variability). It supports clinicians in making decisions on analgesic selection, timing, and dosage.

The 2nd BiiG WAVE IR is an investment-focused program specifically designed for the bio and healthcare sectors, with six companies, including StellarCube, selected to participate. At the main event on September 16, each company will deliver an IR pitch, followed by one-on-one meetings with participating investors to discuss technology, business models, and fundraising plans in greater depth.

Through this program, StellarCube aims to further refine PainCube’s fundraising and commercialization strategy while expanding its network with investors specializing in the bio and healthcare sectors.

Moving forward, StellarCube will continue to validate PainCube’s technological and clinical value, strengthen its commercialization foundation, and progressively advance toward the commercialization of a more objective and proactive pain management solution and its expansion into global markets.